Alexion crowns myasthenia gravis as its best Soliris launch ever

24th October 2018 Uncategorised 0

At the very beginning of 2018, Alexion figured its new Soliris approval in generalized myasthenia gravis could deliver its lead drug’s best launch. Now, as its third-quarter numbers show, that expectation has become a reality.

More: Alexion crowns myasthenia gravis as its best Soliris launch ever
Source: fierce